| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Oct 16, 2026 | Iambic Therapeutics, Inc. (IAM) | P | 718,750 | $16.00 | $11,500,000.00 | View Details Filing |
| Oct 16, 2026 | Iambic Therapeutics, Inc. (IAM) | C | 1,458,736 | - | - | View Details Filing |
| Oct 16, 2026 | Iambic Therapeutics, Inc. (IAM) | C | 410,762 | - | - | View Details Filing |
| Oct 16, 2026 | Iambic Therapeutics, Inc. (IAM) | C | 57,754 | - | - | View Details Filing |
| Oct 16, 2026 | Iambic Therapeutics, Inc. (IAM) | C | 1,152,025 | $0.00 | $0.00 | View Details Filing |
| Oct 16, 2026 | Iambic Therapeutics, Inc. (IAM) | C | 57,754 | $0.00 | $0.00 | View Details Filing |
| Oct 16, 2026 | Iambic Therapeutics, Inc. (IAM) | C | 306,711 | $0.00 | $0.00 | View Details Filing |
| Oct 16, 2026 | Iambic Therapeutics, Inc. (IAM) | C | 410,762 | $0.00 | $0.00 | View Details Filing |
| Oct 14, 2026 | Iambic Therapeutics, Inc. (IAM) | A | 20,300 | $0.00 | $0.00 | View Details Filing |